Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$2.00 | $0.11 | -$0.94 |
| Q2 2026 | 1 | -$1.74 | $0.09 | -$0.82 |
| Q3 2026 | 1 | -$2.85 | $1.18 | -$0.83 |
| Q4 2026 | 2 | -$2.99 | $0.36 | -$1.21 |
| Q1 2027 | 1 | -$1.03 | $0.06 | -$0.48 |
| Q2 2027 | 1 | -$1.05 | $0.06 | -$0.50 |
| Q3 2027 | 1 | -$1.07 | $0.06 | -$0.51 |
| Q4 2027 | 1 | -$1.10 | $0.06 | -$0.52 |
| Q1 2028 | 1 | -$1.12 | $0.06 | -$0.53 |
| Q2 2028 | 1 | -$1.15 | $0.06 | -$0.54 |
| Q3 2028 | 1 | -$1.17 | $0.06 | -$0.55 |
| Q4 2028 | 1 | -$1.20 | $0.06 | -$0.57 |
Lakefront Biothe last posted its earnings results on Monday, August 10th, 2026. The company reported $0.03448 earnings per share for the quarter, topping analysts' consensus estimates of $-0.82265 by $0.85713. The company had revenue of 12.12 M for the quarter and had revenue of 1.11 B for the year. Lakefront Biothe has generated $5 earnings per share over the last year ($4.87 diluted earnings per share) and currently has a price-to-earnings ratio of 3.92. Lakefront Biothe has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 06/30/2026 | Q2 2026 | N/A | $0.03 | N/A | $6.20 M | $12.12 M |
| 03/31/2026 | Q1 2026 | N/A | $0.22 | N/A | $9.59 M | $6.48 M |
| 12/31/2025 | Q4 2025 | N/A | $11.87 | N/A | $82.87 M | $900.82 M |
| 09/30/2025 | Q3 2025 | N/A | -$3.07 | N/A | $76.10 M | $71.16 M |
| 06/30/2025 | Q2 2025 | N/A | -$1.60 | N/A | $80.08 M | $65.29 M |
| 03/31/2025 | Q1 2025 | N/A | -$2.33 | N/A | $71.90 M | $74.98 M |
| 12/31/2024 | Q4 2024 | N/A | $0.29 | N/A | $76.97 M | $75.50 M |
| 09/30/2024 | Q3 2024 | N/A | -$0.74 | N/A | $76.70 M | $59.85 M |
| 06/30/2024 | Q2 2024 | N/A | $0.07 | N/A | $68.84 M | $77.87 M |
| 03/31/2024 | Q1 2024 | N/A | $0.36 | N/A | N/A | $62.43 M |
| 12/31/2023 | Q4 2023 | N/A | -$0.88 | N/A | N/A | $-209,124,000 |
| 09/30/2023 | Q3 2023 | N/A | $0.39 | N/A | N/A | $120.03 M |
| 06/30/2023 | Q2 2023 | N/A | $0.06 | N/A | N/A | $60.05 M |
| 03/31/2023 | Q1 2023 | N/A | -$0.17 | N/A | N/A | $58.57 M |
| 12/31/2022 | Q4 2022 | N/A | -$0.92 | N/A | N/A | $90.11 M |
| 09/30/2022 | Q3 2022 | N/A | $0.33 | N/A | N/A | $136.20 M |
| 06/30/2022 | Q2 2022 | N/A | -$0.29 | N/A | N/A | $137.61 M |
| 03/31/2022 | Q1 2022 | N/A | -$0.20 | N/A | N/A | $136.35 M |
| 12/31/2021 | Q4 2021 | N/A | $0.25 | N/A | N/A | $166.99 M |
| 09/30/2021 | Q3 2021 | N/A | -$0.99 | N/A | N/A | $64.19 M |
In the previous quarter, Lakefront Biothe (:LKFT) reported $0.03448 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.82265 by $0.85713.
The conference call for Lakefront Biothe's latest earnings report can be listened to online.
The conference call transcript for Lakefront Biothe's latest earnings report can be read online.
Lakefront Biothe (:LKFT) has a recorded annual revenue of $1.11 B.
Lakefront Biothe (:LKFT) has a recorded net income of $320.88 M.Lakefront Biothe has generated $4.87 earnings per share over the last four quarters.
Lakefront Biothe (:LKFT) has a price-to-earnings ratio of 3.92 and price/earnings-to-growth ratio is -0.1.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED